Spot Trading’s CorMedix CRMD Stock Holding History

Spot Trading’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,600	Closed	-$185K	–	3681
2015 Q3	$185K	Buy	18,600 +2,440	+15%	+$37.6K	﹤0.01%	2739
2015 Q2	$314K	Buy	16,160 +600	+4%	+$20.6K	﹤0.01%	2414
2015 Q1	$766K	Buy	+15,560	New	+$369K	0.01%	1813

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GLRA

Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Spot Trading's CRMD Position: Q1 2017 in Review

Spot Trading sold out of CorMedix (CRMD) in Q1 2017, closing a stake of 17,487 shares — an estimated $134K sold.

Spot Trading first reported a position in CRMD in Q2 2015 and held it in 6 quarters. The position peaked at $257K in Q4 2015. 30 funds tracked by Wall St. Rank hold CRMD as of Q1 2017.

Spot Trading reported no remaining CorMedix position as of Q1 2017 after selling out during the quarter.
Spot Trading sold 17,487 CorMedix shares in Q1 2017, an estimated $134K.
Spot Trading first reported a position in CorMedix in Q2 2015 and held it in 6 quarters.
Spot Trading's CorMedix position peaked at $257K in Q4 2015.
30 funds tracked by Wall St. Rank held CorMedix as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.